At least two infant deaths reported to the Vaccine Adverse Event Reporting System (VAERS) as occurring after the babies mistakenly received Pfizer’s adult respiratory syncytial virus (RSV) vaccine were likely caused instead by nirsevimab, the monoclonal antibody shot approved for infants and meant to prevent RSV.
Freedom of Information Act (FOIA) documents obtained by Children’s Health Defense (CHD) from the Centers for Disease Control and Prevention (CDC) show that both babies died on the day they received the shots.
According to the reports in VAERS, a 27-day-old boy died immediately upon receiving the shot in the doctor’s office and an infant girl was found not breathing by her father seven hours after receiving the shot. The infant was pronounced dead soon after.
The deaths were reported in VAERS as resulting from mistaken administration of Pfizer’s adult RSV vaccine, but the CDC internal emails obtained by CHD indicate the babies had been administered Beyfortus, the brand name for nirsevimab, manufactured by AstraZeneca and Sanofi.
